Abstract

Purpose: A new macromolecular MR contrast agent, Gd-DTPA-24-cascade-polymer, was assessed for MR angiography of peritumoral vessels in rats. Material and methods: High resolution 3D-SPGR (TR/TE 100/5ms, α = 90°) angiograms were acquired in 10 Fischer rats bearing subcutaneous R3230 mammary adenocarcinomas. MRI was performed before, immediately and 40 min after administration of Gd-DTPA (0.1 mmol Gd/kg), and after either Gd-DTPA-cascade-polymer or albumin-(Gd-DTPA) 30 (each 0.05 mmol Gd/kg). A semi-quantitative analysis of small peritumoral vessels and tumor rim enhancement was performed on maximum intensity projection (MIP) angiograms using a 4-point scoring system. A quantitative analysis compared vascular signal-to-background-(S/B), signal-to-noise-, and contrast-to-noise-ratio. Results: Gd-DTPA produced a transient and low-scoring vessel definition (0.2 ± 0.1), but strong rim enhancement (score 1.7 ± 0.1). The cascade polymer resulted in better but submaximal vessel delineation (score 1.6 ± 0.3, S/B 5.0 ± 0.2) and strong rim enhancement (score 1.8 ± 0.1). Albumin-(Gd-DTPA) 30 produced the best and most time-persistent angiograms (score 2.6 ± 0.2, S/B 7.4 ± 0.2), but minimal rim enhancement (score 0.3 ± 0.2). Conclusion: The Gd-DTPA-24-cascade-polymer demonstrated the useful combination of strong tumor rim enhancement and detailed angiographic definition of peritumoral vessels. These are advantages associated with extracellular and blood pool contrast media, respectively.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.